Orion Biotechnology is developing a pipeline of best-in-class biologic therapeutics based on Chemokine Analogue inhibitors, for the treatment of a broad range of serious unmet medical needs.

Biotechnology

Health Care

Orion Biotechnology

Orion Biotechnology's headquarters in Ottawa, Canada

Mark Groper

Anatole Klepatsky

The Leadership Team at Orion Biotechnology is responsible for guiding the strategic vision and operational execution of the company's innovative pipeline of biologic therapeutics. This cross-functional team, consisting of experts in medical, operational, financial, and research domains, ensures alignment with the company’s mission to address serious unmet medical needs through the development of Chemokine Analogue inhibitors. Their collaborative efforts drive decision-making, funding strategies, and clinical development to advance Orion's therapeutic candidates towards successful commercialization.

Leadership Team

The Research and Development team at Orion Biotechnology is dedicated to advancing the company's innovative pipeline of biologic therapeutics. Comprising scientists and project managers, the team conducts extensive research to develop Chemokine Analogue inhibitors, designs and executes experiments, and oversees the progression of projects from conception through preclinical trials, ensuring alignment with the company's goals of addressing serious unmet medical needs.

Orion Biotechnology

Org chart

Teams

Leadership Team

Research and Development

Offices

Orion Biotechnology

Org chart

Teams

Leadership Team

Research and Development

Offices

Related companies